SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Winsor, T.
Right arrow Articles by Bernett, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winsor, T.
Right arrow Articles by Bernett, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of Coronary Vasodilating Drug on Myocardial Work

Travis Winsor

Memorial Heart Research Foundation, Los Angeles, St. Vincent Medical Center, University of Southern California, School of Medicine

David W. Winsor

Diplomate of the American Board of Nuclear Medicine, St. Vincent Medical Center

Bernard G. Krohn

St. Vincent Medical Center

Jorge R. Bernett

Research Assistant for Memorial Heart Research Foundation

The purpose of this paper is to show, by noninvasive measurements, previously undocumented effects on cardiac work of the nitrate coronary vasodilator Pentaerythritol Tetranitrate (Peritrate®). The chew-and-swallow 40-mg tablets of this drug were given to 10 patients of type II AHA classifica tion. The Diastolic Time Tension Index/Systolic Time Tension Index Ratio increased significantly from 1.15 (±0.11 SEM) to 1.46 (±0.13), p<0.05. The Double Product decreased significantly from 9813 (±606) to 8336 (±497), p<0.01. The Triple Product also decreased significantly from 3223 (±235) to 2425 (±206), p<0.01. The percent diastole of the R-R interval increased signifi cantly from 65% (±2.44) to 70% (± 1.73) p<0.05, while no significant change in heart rate occurred (63.2 bts/min to 62.4 bts/min). Correspondingly, there was a decrease of systolic time interval, from 0.33 second (±0.2) to 0.29 second (±.01) p<0.01. A significant decrease in blood pressure was also noted. Sys tolic BP dropped from 155 (±8.0) to 134(±7.2),p<0.01. Diastolic BP dropped from 89.2 (±2.8) to 79.2 (±2.2), p<0.01. This study shows that Peritrate produced significantly favorable changes in all the cited indicators of cardiac work.

Angiology, Vol. 33, No. 6, 393-400 (1982)
DOI: 10.1177/000331978203300605


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement